Results 11 to 20 of about 56,222 (207)
Background – The caninised monoclonal antibody lokivetmab (LKV), directed at interleukin (IL)‐31, is very effective at controlling pruritus in most dogs with atopic dermatitis (AD). However, evidence exists that IL‐31 is not required for the induction of acute allergic skin inflammation, which might explain why this treatment is less efficacious in ...
Chie Tamamoto‐Mochizuki +4 more
wiley +1 more source
Anticorpos antifosfolipídios: novos critérios [PDF]
Suggested modifications of the clinical diagnostic criteria of antiphospholipid antibody syndrome and therapeutic approaches are related in this letter.
Godoy, José M.P. +2 more
openaire +3 more sources
SISTEMA LW – RELATO DE CASO DE ANTICORPO IRREGULAR MIMETIZANDO ANTICORPO ANTI-D
Introdução: O sistema de grupo sanguíneo LW teve sua identificação na década de 40, com os estudos do Sistema Rh, sendo inicialmente considerado o equivalente a este último em animais. Em 1963 foi confirmado como um sistema de grupo sanguíneo independente e recebeu este nome em homenagem a Landsteiner e Wiener, que foram os primeiros a identificarem ...
MC Mendonça +9 more
openaire +2 more sources
Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases
Background –Canine atopic dermatitis (cAD) is an allergic skin disease affecting approximately 10% of dogs. Allergen immunotherapy (AIT) is currently the only treatment option able to induce tolerance to the causative allergens. Objective – To retrospectively establish the efficacy of AIT in atopic dogs.
Evelien E. M. Fennis +6 more
wiley +1 more source
Abstract Through active surveillance and contact tracing from outpatients, we aimed to identify and characterize SARS‐CoV‐2 variants circulating in Porto Velho‐Rondônia, a city in the Brazilian Amazon. As part of a prospective cohort, we gathered information from 2,506 individuals among COVID‐19 patients and household contacts.
Gabriella S. Oliveira +15 more
wiley +1 more source
Background – Interleukin (IL)‐31 is an important mediator in canine atopic dermatitis (cAD) and also may be dysregulated in other allergic diseases. Hypothesis/Objectives – To demonstrate the efficacy and safety of lokivetmab (canine anti‐IL‐31 monoclonal antibody) for treatment of pruritus associated with allergic dermatitis in dogs.
Leen Van Brussel +4 more
wiley +1 more source
Immunopathogenesis of the feline atopic syndrome
Résumé Contexte Les maladies félines supposées d’origine allergique avec des phénotypes cliniques semblables, peuvent avoir de nombreuses pathogénies différentes sous jacentes. Le phénotype clinque, l’étiologie précise et l’immunopathogénie sous jacente doivent tous être considérés si des avancées veulent être faites dans ces domaines négligés de la ...
Richard Halliwell +3 more
wiley +1 more source
Socioecology and Prevalence of SARS-CoV-2 Infection in Quilombolas Living in the Brazilian Amazon. [PDF]
ABSTRACT Objectives This cross‐sectional study presents socioecological, epidemiological aspects, and the seroprevalence of immunoglobulin G (IgG) against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in a group of quilombola (afro‐derived) communities in the states of Pará and Tocantins, in the Brazilian Amazon, to evaluate the impact ...
Pereira KAS +19 more
europepmc +2 more sources
Background – Thymus and activation‐regulated chemokine (TARC/CCL17) has been implicated in the pathogenesis of canine atopic dermatitis (cAD). Serum TARC concentrations are a reliable biomarker for human atopic dermatitis; however, their potential as a biomarker for cAD has not been investigated.
Ryota Asahina +8 more
wiley +1 more source
Risk factors associated with Toxoplasma gondii infection in dairy cattle, state of Rio de Janeiro
Toxoplasmosis is one of the most common parasitic zoonoses throughout the world. Infection in man and animals varies in different geographical areas influenced by many environmental conditions.
G.R. Albuquerque +5 more
doaj +1 more source

